Malignant peripheral nerve sheath tumor: Molecular pathogenesis and current management considerations

Journal of Surgical Oncology

Volumn 97, Issue 4, 2008, Pages 340-349

  Grobmyer, Stephen R ^a,b   Reith, John D ^a   Shahlaee, Amir ^a   Bush, Charles H ^a   Hochwald, Steven N ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Chemotherapy; Malignant peripheral nerve sheath tumor; Neurofibromatosis; Pathogenesis; Radiation therapy; Review; Surgery

Indexed keywords

CARBOPLATIN; DOCETAXEL; DOXORUBICIN; ERLOTINIB; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; IMATINIB;

ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CHROMOSOME ABERRATION; CLINICAL FEATURE; CLINICAL TRIAL; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; MAINTENANCE THERAPY; MICROARRAY ANALYSIS; NERVE SHEATH TUMOR; NEUROFIBROMATOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SURVIVAL RATE;

EID: 40549094329     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20971     Document Type: Review

References (100)